ROCKLAND, Mass., April 17 /PRNewswire/ -- Fertility LifeLines(TM) and
Conceive Magazine today released new survey data illustrating the need for
resources for women seeking information about fertility health. The survey,
supported by a leading fertility company EMD Serono, looked at unfulfilled
needs of women and couples seeking information on infertility and provides
new insights into the emotional impact of infertility. These issues, along
with tips for handling one's personal experience with infertility, are
addressed in a new free booklet provided by Fertility LifeLines(TM) and
Conceive Magazine entitled In The Know: What No One Tells You About
The online survey, which was completed by 714 women, found:
-- Women are waiting longer than recommended before seeking medical
advice about fertility issues. It is commonly recommended that couples
should seek medical help from a Fertility Specialist if they are
unable to become pregnant after one year of regular, unprotected
intercourse, or six months if the woman is over 35 years of age. Of
all survey respondents, 64 percent have been trying to conceive for
one year or more, and nearly one-third (32 percent) are waiting to
seek medical help.
-- Women are surprised when it happens to them. The survey found that
although 86 percent of all respondents knew at least one person who
had trouble getting pregnant and 40 percent knew three or more people
who struggled to get pregnant, 70 percent were surprised when they had
trouble initially getting pregnant themselves.
-- Women experience an emotional rollercoaster when it comes to fertility
issues. Survey respondents reported feeling stress (52 percent),
jealousy of other people's happy baby news (44 percent) and depressed
or sad (41 percent), most of the time. They also reported that they
felt fear (78 percent), anger (77 percent) and loss of control (54
percent) at least some of the time.
"This survey found that there is a great need to provide women
additional information on how to handle the emotional and financial
stresses associated with experiencing infertility," said Kim Hahn, founder
and CEO, Conceive. "The goal of the In The Know booklet was to address
those and the many issues surrounding fertility concerns in a quick read,
written in a friendly, candid, girlfriend-to-girlfriend style."
The In The Know: What No One Tells You About Fertility booklet covers
topics such as an overview of treatment options, tips on handling the
additional stress in your relationship, working with your doctor to
determine your treatment plan including financial considerations and
talking to your partner about your concerns. Alice D. Domar, Ph.D.,
Assistant Professor at Harvard Medical School, Founder and Director of the
Domar Center for Mind/Body Health at Boston IVF, acclaimed author and the
"Fertility Goddess" according to Vogue, wrote the foreword to the In The
"With current medical advances in fertility treatments, women are
having more success getting pregnant today than they were just 10 years
ago," said Dr. Domar. "Unfortunately, women are waiting longer than
necessary to seek medical help because they are concerned with both the
emotional and financial impact of treatment. The In The Know booklet is a
great resource for these women."
Infertility is defined as the inability to conceive after one year of
regular, unprotected intercourse, or six months if the woman is over 35
years of age. It affects about six million Americans, which represents
about one in seven couples in their childbearing years. The majority of
patients who complete treatment succeed in having a child.
Where Are Women Getting Infertility Information and Advice?
According to the survey, in addition to their healthcare provider more
than 50 percent of women get information from health and women's magazines
and 78 percent get information from Web sites and blogs. Women also seek
information from girlfriends (42 percent), support groups (18 percent),
family members (23 percent) and their partner (20 percent).
Only about half of survey respondents felt that the available
information on infertility is sufficient; of the remainder:
-- 23 percent felt there wasn't enough information on emotional issues.
-- 22 percent needed additional information on dealing with stress.
-- 22 percent wanted more male-oriented information.
"As a company, we are committed to providing women and couples with
knowledge they can use at every step throughout their fertility journey,"
said Jim Hoyes, Chief Commercial Officer, EMD Serono, Inc. "We will
continue to invest in programs and resources that allow patients access to
an array of educational materials like the In The Know guide and Fertility
Women and healthcare providers can order a complimentary copy of In The
Know: What No One Tells You About Fertility by registering at
www.FertilityLifeLines.com or by calling Fertility LifeLines(TM) at
About the Survey
Fertility LifeLines(TM) and Conceive Magazine co-sponsored a survey
answered by 714 women about their experience with fertility concerns. The
survey took place over a five week time period from 12/21/07 to 01/25/08.
The average age of the women surveyed was approximately 35 years. The
survey was posted on the Survey Monkey Web site and distributed to over
About Fertility LifeLines(TM)
Fertility LifeLines(TM) is a free and confidential educational service
offering customized information and support to people with fertility health
concerns, provided by EMD Serono. Fertility LifeLines(TM) is available by
calling toll-free 1-866-LETS-TRY (1-866-538-7879), or via the Web at
www.FertilityLifeLines.com. It is staffed with highly trained customer
service representatives, infertility nurses and benefits specialists ready
to assist callers with: general infertility information, insurance
assistance, local Fertility Specialist referral, EMD Serono product
support, and emotional support through compassionate listening to help put
the patient journey into perspective and provide information about
additional support and resources.
Conceive provides information and inspiration for women who have
embarked on the journey to parenthood. In print (Conceive Magazine and
books, including the new The Fertility Journal, A Day-by-Day Guide to
Getting Pregnant and Fertility Facts, Hundreds of Tips for Getting
Pregnant), online (www.conceiveonline.com) and on the air (Conceive's
weekly Internet radio show, Conceive On-Air), Conceive thoroughly covers
the topic of family- building, including preconception health, fertility
and infertility, natural conception and fertility treatments, and adoption.
Through all available media outlets, Conceive provides accurate and crucial
information for women in this exciting stage of their lives.
About EMD Serono, Inc.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a
leader in the US biopharmaceutical arena, integrating cutting-edge science
with unparalleled patient support systems to improve people's lives. EMD
Serono is a leader in fertility treatments, with Gonal-f(R) (follitropin
alfa for injection), Luveris(R) (lutropin alfa for injection) and
Ovidrel(R) Prefilled Syringe (choriogonadotropin alfa injection). The
company has strong market positions in neurodegenerative diseases, with
Rebif(R) (interferon beta-1a), as well as in endocrinology, with Saizen(R)
[somatropin (rDNA origin) for injection], Serostim(R) [somatropin (rDNA
origin) for injection] and Zorbtive(TM) [somatropin (rDNA origin) for
injection]. With a clear focus on the patient and a leadership presence in
the biopharmaceutical industry, EMD Serono's US footprint continues to
grow, with more than 850 employees around the country and fully integrated
commercial, clinical and research operations in the company's home state of
For more information, please visit www.emdserono.com
About Merck KGaA
Merck is a global pharmaceutical and chemical company with total
revenues of EUR 7.1 billion in 2007, a history that began in 1668, and a
future shaped by 30,968 employees in 60 countries. Its success is
characterized by innovations from entrepreneurial employees. Merck's
operating activities come under the umbrella of Merck KGaA, in which the
Merck family holds an approximately 70% interest and free shareholders own
the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co.
was expropriated and has been an independent company ever since.
For more information, please visit www.merck.de
SOURCE EMD Serono, Inc.